Ken Fisher's CLB Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 774,979 shares of Core Laboratories Inc. (CLB) worth $12.42 M, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in CLB, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2023, adding 430,756 shares. Largest reduction occurred in Q2 2022, reducing 673,711 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Core Laboratories (CLB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Core Laboratories (CLB) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -49,600 | Reduce 6.02% | 774,979 | $16.03 |
| Q3 2025 | -43,147 | Reduce 4.97% | 824,579 | $12.36 |
| Q2 2025 | -143,838 | Reduce 14.22% | 867,726 | $11.52 |
| Q1 2025 | +70,295 | Add 7.47% | 1.01 M | $14.99 |
| Q4 2024 | -48,998 | Reduce 4.95% | 941,269 | $17.31 |
| Q3 2024 | +161,278 | Add 19.45% | 990,267 | $18.53 |
| Q2 2024 | +4,844 | Add 0.59% | 828,989 | $20.29 |
| Q1 2024 | +69,738 | Add 9.24% | 824,145 | $17.08 |
| Q4 2023 | +134,227 | Add 21.64% | 754,407 | $17.66 |
| Q3 2023 | +430,756 | Add 227.40% | 620,180 | $24.01 |
| Q1 2023 | -687 | Reduce 0.36% | 189,424 | $22.05 |
| Q4 2022 | +116 | Add 0.06% | 190,111 | $20.27 |
| Q3 2022 | -200 | Reduce 0.11% | 189,995 | $13.48 |
| Q2 2022 | -673,711 | Reduce 77.98% | 190,195 | $19.81 |
| Q1 2022 | +26,827 | Add 3.20% | 863,906 | $31.63 |
| Q4 2021 | +240,721 | Add 40.37% | 837,079 | $22.31 |
| Q3 2021 | -163,674 | Reduce 21.54% | 596,358 | $27.75 |
| Q2 2021 | -74,318 | Reduce 8.91% | 760,032 | $38.95 |
| Q1 2021 | -50,904 | Reduce 5.75% | 834,350 | $28.79 |
| Q4 2020 | -1,140 | Reduce 0.13% | 885,254 | $26.51 |
| Q3 2020 | -21,743 | Reduce 2.39% | 886,394 | $15.26 |
| Q2 2020 | -22,694 | Reduce 2.44% | 908,137 | $20.32 |
| Q1 2020 | -77,652 | Reduce 7.70% | 930,831 | $10.34 |
| Q4 2019 | -59,694 | Reduce 5.59% | 1.01 M | $37.67 |
| Q3 2019 | -7,633 | Reduce 0.71% | 1.07 M | $46.62 |
| Q2 2019 | -12,613 | Reduce 1.16% | 1.08 M | $52.28 |
| Q1 2019 | +319,148 | Add 41.49% | 1.09 M | $68.93 |
| Q4 2018 | +47,867 | Add 6.64% | 769,275 | $59.66 |
| Q3 2018 | +270,723 | Add 60.07% | 721,408 | $115.83 |
| Q2 2018 | +12,671 | Add 2.89% | 450,685 | $126.21 |
| Q1 2018 | +438,014 | New Buy | 438,014 | $108.22 |
Ken Fisher's Core Laboratories Investment FAQs
Ken Fisher first purchased Core Laboratories Inc. (CLB) in Q1 2018, acquiring 438,014 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Core Laboratories Inc. (CLB) for 32 quarters since Q1 2018.
Ken Fisher's largest addition to Core Laboratories Inc. (CLB) was in Q1 2018, adding 438,014 shares worth $47.4 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 774,979 shares of Core Laboratories Inc. (CLB), valued at approximately $12.42 M.
As of the Q4 2025 filing, Core Laboratories Inc. (CLB) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Core Laboratories Inc. (CLB) was 1,088,423 shares, as reported at the end of Q1 2019.